Promoters show minimal activity with a slight YoY decline, while Institutions are increasing their holdings, indicating cautious optimism; however, the overall trend aligns with sector averages where both Promoter and Institutional activity is flat.

Institutional shareholding in Aurobindo Pharma increased by 2.30% YoY, contrasting with the sector's 0% change, suggesting that while the stock has some support, it doesn't significantly diverge from sector trends.

The sector is experiencing notable movements, with Sanoficonr seeing a 20.63% increase in Institutional shareholding, indicating stronger interest in certain peers compared to Aurobindo Pharma.